Compare ALTG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTG | BIOA |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.3M | 175.7M |
| IPO Year | N/A | 2024 |
| Metric | ALTG | BIOA |
|---|---|---|
| Price | $5.21 | $12.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $11.33 | $11.33 |
| AVG Volume (30 Days) | 230.3K | ★ 410.3K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,824,900,000.00 | $5,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.54 | $2.88 |
| 52 Week High | $8.99 | $13.10 |
| Indicator | ALTG | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 77.17 |
| Support Level | $4.61 | $12.00 |
| Resistance Level | $5.84 | $13.10 |
| Average True Range (ATR) | 0.24 | 0.72 |
| MACD | 0.13 | 0.26 |
| Stochastic Oscillator | 52.34 | 87.28 |
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.